Drug & medication recalls High risk

Ferring Pharmaceuticals Inc recalls STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL B…

Recall date
July 21, 2020
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-1506-2020
FDA classification
Class I
Brand / firm
Ferring Pharmaceuticals Inc
Sold / distributed
Nationwide within the United States.

Why it was recalled

Superpotent Drug

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL Behring LLC, King of Prussia, PA 19406-0901; By: Ferring GmbH, Kiel, Germany, NDC 0053-6871-00

Get recall alerts

Free email alert whenever Ferring Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Ferring Pharmaceuticals Inc